Skip to content
Screener

Cytek Biosciences, Inc. CTKB EMEA — Total revenue, net

Other geography segments

APAC
$7.92M+0.6%
Other
$701K-54.2%

Similar metrics at other companies

Viavi Solutions Inc. logo
VIAVEMEA: — Total net revenue
$95.8M+26.1%
A10 Networks logo
ATENEMEA — Total net revenue
$8.64M-15.7%
BK
BKEMEA — Total Revenue
$1.14B+6.9%
Adobe logo
ADBEEMEA — Total Revenue
$1.81B+17.4%
Ciena logo
CIENEMEA — Total Revenue
$196.04M+2.3%
Rubrik logo
RBRKEMEA — Total Revenue
$92.19M+42.4%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$28,220$23,894$52,607$42,429
EMEA11,30412,30922,06923,875
APAC7,9157,86715,66616,758
Other7011,5321,9333,997
Total revenue, net$48,140$45,602$92,275$87,059

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s EMEA — total revenue, net?
Cytek Biosciences, Inc. (CTKB) reported EMEA — total revenue, net of $11.3M in Q2 2026.
How has Cytek Biosciences, Inc.'s EMEA — total revenue, net changed year-over-year?
Cytek Biosciences, Inc.'s EMEA — total revenue, net decreased by 8.2% year-over-year, from $12.31M to $11.3M.
What is the long-term trend for Cytek Biosciences, Inc.'s EMEA — total revenue, net?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s EMEA — total revenue, net has grown at a 10.9% compound annual growth rate (CAGR), from $36.97M to $55.88M.
What does EMEA — total revenue, net mean?
This metric represents the total net revenue generated from the sale of products and services within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and commercial success in these territories, serving as a key indicator of regional demand for cell analysis solutions. Investors use this to assess the geographic diversification of the company's revenue streams and the effectiveness of its international sales strategy.

Ask your AI about Cytek Biosciences, Inc.'s emea — total revenue, net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude